Your browser doesn't support javascript.
loading
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Peluso, Michael J; Takahashi, Saki; Hakim, Jill; Kelly, J Daniel; Torres, Leonel; Iyer, Nikita S; Turcios, Keirstinne; Janson, Owen; Munter, Sadie E; Thanh, Cassandra; Donatelli, Joanna; Nixon, Christopher C; Hoh, Rebecca; Tai, Viva; Fehrman, Emily A; Hernandez, Yanel; Spinelli, Matthew A; Gandhi, Monica; Palafox, Mary-Ann; Vallari, Ana; Rodgers, Mary A; Prostko, John; Hackett, John; Trinh, Lan; Wrin, Terri; Petropoulos, Christos J; Chiu, Charles Y; Norris, Philip J; DiGermanio, Clara; Stone, Mars; Busch, Michael P; Elledge, Susanna K; Zhou, Xin X; Wells, James A; Shu, Albert; Kurtz, Theodore W; Pak, John E; Wu, Wesley; Burbelo, Peter D; Cohen, Jeffrey I; Rutishauser, Rachel L; Martin, Jeffrey N; Deeks, Steven G; Henrich, Timothy J; Rodriguez-Barraquer, Isabel; Greenhouse, Bryan.
  • Peluso MJ; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA. michael.peluso@ucsf.edu.
  • Takahashi S; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Hakim J; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Kelly JD; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Torres L; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Iyer NS; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Turcios K; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Janson O; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Munter SE; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Thanh C; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Donatelli J; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Nixon CC; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Hoh R; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Tai V; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Fehrman EA; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Hernandez Y; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Spinelli MA; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Gandhi M; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Palafox MA; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Vallari A; Abbott Laboratories, Abbott Park, IL, USA.
  • Rodgers MA; Abbott Laboratories, Abbott Park, IL, USA.
  • Prostko J; Abbott Laboratories, Abbott Park, IL, USA.
  • Hackett J; Abbott Laboratories, Abbott Park, IL, USA.
  • Trinh L; Abbott Laboratories, Abbott Park, IL, USA.
  • Wrin T; Monogram Biosciences Inc., South San Francisco, CA, USA.
  • Petropoulos CJ; Monogram Biosciences Inc., South San Francisco, CA, USA.
  • Chiu CY; Monogram Biosciences Inc., South San Francisco, CA, USA.
  • Norris PJ; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • DiGermanio C; Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA, USA.
  • Stone M; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Busch MP; Vitalant Research Institute, San Francisco, CA, USA.
  • Elledge SK; Vitalant Research Institute, San Francisco, CA, USA.
  • Zhou XX; Vitalant Research Institute, San Francisco, CA, USA.
  • Wells JA; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Shu A; Vitalant Research Institute, San Francisco, CA, USA.
  • Kurtz TW; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
  • Pak JE; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
  • Wu W; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
  • Burbelo PD; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
  • Cohen JI; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Rutishauser RL; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Martin JN; Chan Zuckerberg Biohub, San Francisco, CA, USA.
  • Deeks SG; Chan Zuckerberg Biohub, San Francisco, CA, USA.
  • Henrich TJ; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
  • Rodriguez-Barraquer I; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Greenhouse B; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.
Sci Adv ; 7(31)2021 Jul.
Article en En | MEDLINE | ID: mdl-34330709